DOCSLIB.ORG

AP-1-MEDIATED REGULATION of HPV CHROMATIN TRANSCRIPTION by WEI-MING WANG Submitted in Partial Fulfillment of the Requirements Fo

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
AP-1-MEDIATED REGULATION of HPV CHROMATIN TRANSCRIPTION by WEI-MING WANG Submitted in Partial Fulfillment of the Requirements Fo AP-1-MEDIATED REGULATION OF HPV CHROMATIN TRANSCRIPTION by WEI-MING WANG Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Advisor: Dr. Cheng-Ming Chiang Department of Biochemistry CASE WESTERN RESERVE UNIVERSITY May, 2008 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ______________________________________________________ candidate for the Ph.D. degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. Copyright © 2008 by Wei-Ming Wang All rights reserved TABLE OF CONTENTS Acknowledgements………………………………………………………………... 9 Glossary…………………………………………………………………………… 11 Abstract……………………………………………………………………………. 13 CHAPTER 1. GENERAL INTRODUCTION TO TRANSCRIPTIONAL REGULATION IN HUMAN PAPILLOMAVIRUSES………….. 15 Human Papillomaviruses………………………………………………... 15 Human Papillomaviruses and Human Diseases……………………. 15 HPV Biology……………………………………………………….. 17 Lessons Learned from Cervical Carcinogenesis…………………… 22 Regulation of HPV Oncogene Expression…………………………. 23 AP-1: a Ubiquitous Transcription Factor with Multiple Functions……... 26 Human AP-1 Complexes…………………………………………. 26 Regulation of AP-1 Activity……………………………………… 32 AP-1 and Skin Biology…………………………………………… 37 AP-1 Regulates HPV Oncogene Expression……………………….. 38 Mechanism of Transcriptional Initiation from Chromatin………………. 41 CHAPTER 2. EXPRESSION AND PURIFICATION OF FULL-LENGTH HUMAN DIMERIC AP-1 COMPLEXES USING A BACTERIAL POLYCISTRONIC EXPRESSION SYSTEM…... 46 Introduction……………………………………………………………… 46 Materials and Methods…………………………………………………... 50 Plasmid Constructions……………………………………………..... 50 Expression and Purification of Recombinant Full-Length Human AP-1 Complexes........................................................................... 52 Electrophoretic Mobility Shift Assay (EMSA)……………………... 55 In Vitro Transcription Assay………………………………………… 56 Results…………………………………………………………………… 57 Generation of Polycistronic Bacterial Expression Plasmids for Distinct Human AP-1 Complexes……………………………….. 57 Purification of Recombinant Human AP-1 Complexes…………….. 59 DNA Binding Activity of Purified Recombinant Human AP-1 Complexes………………………………………………………. 64 1 In Vitro Transcription Activated by Recombinant AP-1 Complexes Purified from the In Vitro or In Vivo Reconstitution Method…………………………………………………………... 70 Discussion……………………………………………………………….. 73 CHAPTER 3. CHARACTERIZATION OF PUTATIVE AP-1 BINDING 80 SITES IN HPV-11 URR…………………………………………. Introduction……………………………………………………………… 80 Materials and Methods…………………………………………………... 86 Plasmid Constructions………………………………………………. 86 Protein Expression and Purification ………………………………... 86 Electrophoretic Mobility Shift Assay (EMSA)……………………... 90 Calculation of the Fractional Occupancy…………………………… 91 Transient Transfection and Reporter Gene Assays……………….… 91 DNase I Footprinting………………………………………………... 92 Results…………………………………………………………………… 93 Five Putative AP-1 Sites in the HPV-11 URR Are Bound Differentially by Distinct Human AP-1 Complexes…………….. 93 AP-1 DNA Binding Activity Is Enhanced by Acetylation………….. 102 The Promoter-Proximal AP-1 Site Is Critical for HPV-11 E6 Promoter Activity in C-33A Cells…………………………….… 104 Discussion……………………………………………………………….. 107 Multiple AP-1 Binding Sites Are Well Conserved in HPV URRs….. 107 A Highly Conserved E6 Promoter-Proximal AP-1 Site Found in Genital HPVs……………………………………………………. 108 Redundant Occupancy of the Consensus-Like HPV E6 Promoter-Proximal AP-1 Site…………………………………… 110 The Promoter-Proximal AP-1 Site Is critical for HPV-11 E6 Promoter Activity in the Human C-33A Cell Line……………… 113 The Important Biolgical Role of Redundant Promoter Occupancy……………………………………………………..... 114 CHAPTER 4. MECHANISM OF TRANSCRIPTIONAL ACTIVATION OF THE HPV E6 PROMOTER MEDIATED BY HUMAN AP-1 COMPLEXES…………………………………………………… 116 Introduction……………………………………………………………… 116 2 Materials and Methods…………………………………………………... 121 Plasmid Constructions………………………………………………. 121 Protein Expression and Purification………………………………… 121 Chromatin Assembly and In Vitro Transcription Assay…………….. 121 Order-of-Addition Experiment……………………………………… 122 In Vitro HAT Assay…………………………………………………. 123 Immobilized AP-1 Pull-Down Assay……………………………….. 123 Reverse Transcription-PCR…………………………………………. 124 In Vivo Chromatin Immunoprecipitation (ChIP) Assay…………..… 125 Protein Detection in Cultured Cell Lines…………………………… 126 Antibodies…………………………………………………………... 126 Results…………………………………………………………………… 127 HPV Chromatin Transcription Can be Activated by Distinct Human AP-1 Complexes In Vitro…………………………………….. 127 Acetylation of HPV Chromatin Mediated by p300 Is an AP-1-Dependent Event……………………………………….. 131 HAT Activity of p300 Is Required for AP-1-Dependent HPV Chromatin Transcription In Vitro……………………………... 134 Direct Protein-Protein Interaction Is Required for the Recruitment of p300 to Support AP-1-Dependent HPV Chromatin Transcription………………………………………………….. 137 p300 is Recruited to the Activated HPV E6 Promoter to Perform Targeted Nucleosomal Acetylation in an AP-1-Dependent Manner In Vivo………………………………………………... 143 Discussion……………………………………………………………….. 150 Reconstituted HPV Chromatin Transcription Is Activated by Distinct AP-1 Complexes to Different Extents……………….. 150 p300 Is Essential for AP-1-Dependent HPV Gene Regulation.…….. 152 Possible Cofactors Involved in AP-1-Dependent HPV Gene Regulation…………………………………………………….. 154 Fra-1 May Act as a Competitive Inhibitor of c-Fos in AP-1-Dependent HPV Chromatin Transcription……………... 156 Fra-1 Is a Transcriptional Activator………………………………… 159 Molecular Insights for Positive and Negative Regulation of HPV Gene Expression……………………………………………… 161 3 CHAPTER 5. POST-TRANSLATIONAL MODIFICATION OF AP-1 COMPLEXES…………………………………………………… 165 Introduction……………………………………………………………… 165 Materials and Methods…………………………………………………... 174 Plasmid Constructions………………………………………………. 174 Protein Expression and Purification………………………………… 174 Electrophoretic Mobility Shift Assay (EMSA)……………………... 175 AP-1 In Vitro Acetylation Assay……………………………………. 176 Chromatin Assembly and In Vitro Transcription Assay…………..… 176 Results…………………………………………………………………… 177 The DNA Binding Activity of AP-1 Is Enhanced by p300-Mediated Acetylation……………………………………………………. 177 The DNA Binding Activity of AP-1 Is Enhanced by Human Ref-1.......................................................................................... 179 Discussion……………………………………………………………….. 183 CHAPTER 6. CONCLUSIONS AND FUTURE PERSPECTIVES……………. 192 Appendix A. Primers Used for Cloning of cDNAs Encoding Each Member of Human Jun and Fos Family Proteins…………………………... 196 Appendix B. Monocistronic Expression Plasmids of Human AP-1 Subunits…... 197 Appendix C. Polycistronic Expression Plasmids of Human AP-1 Complexes..... 199 Appendix D. Analysis of Purified Recombinant Human AP-1 Complexes…….. 201 Appendix E. In Vitro Chromatin Assembly and Transcription Using DNA Templates Containing HPV-11 URR AP-1 Site Mutateds in p7072-70G-Less/I+ (WT) Cassettes……………………………. 215 References…………………………………………………………………………. 218 4 LIST OF TABLES Table 1. Constructed plasmids expressing dimeric human AP-1 complexes........ 58 Table 2. Design of DNA fragments containing AP-1 binding sites for EMSA………………………………………………………………….. 85 Table 3. Primers used for mutagenesis of AP-1 binding sites in HPV-11 URR……………………………………………………………………. 87 Table 4. Primers used for generation of individual AP-1 binding site-containing DNA fragments for EMSA……………………….................................. 89 Table 5. Equilibrium binding constant (Kd) for individual AP-1 binding to each AP-1 site-containing DNA probe……………………………................ 98 5 LIST OF FIGURES Fig. 1. Schematic representation of the DNA genome of HPV-11…………… 18 Fig. 2. Sequence alignment of the conserved bZIP motifs within the Jun and Fos protein families…………………………………………………… 28 Fig. 3. Analysis of purified recombinant F:c-Jun/6His:FosB heterodimeric AP-1 complex…………………………………………………………. 61 Fig. 4. Coexpression enhances the stability of recombinant full-length human JunB protein expressed in E. coli……………………………………... 62 Fig. 5. Coomassie blue-stained gels of distinct purified recombinant human AP-1 complexes……………………………………………………….. 63 Fig. 6. Purified recombinant c-Jun/c-Fos binds to TRE in a sequence-specific manner………………………………………………………………… 66 Fig. 7. All the five c-Jun-containing AP-1 complexes exhibit robust DNA binding activity………………………………………………………... 67 Fig. 8. Heterodimeric AP-1 complexes exhibit stronger DNA binding activity than the homodimer…………………………………………………… 68 Fig. 9. Outline of the preparation of human AP-1 complexes from the initial construction of plasmids to the final step of purification……………... 69 Fig. 10. In vivo reconstituted c-Jun/c-Fos exhibits comparable transactivation activity as that reconstituted in vitro…………………………………... 72 Fig. 11. Plasmids used as templates for generation of DNA fragments containing individual wild-type or mutated AP-1 sites for EMSA…… 88 Fig. 12. Five putative AP-1 sites in the HPV-11 URR are differentially bound by distinct human AP-1 complexes…………………………………… 96 6 Fig. 13. Individual putative AP-1 sites exhibit different
Load more

Recommended publications
  • The Thioredoxin Trx-1 Regulates the Major Oxidative Stress Response Transcription Factor, Skn-1, in Caenorhabditis Elegans
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 5-2016 THE THIOREDOXIN TRX-1 REGULATES THE MAJOR OXIDATIVE STRESS RESPONSE TRANSCRIPTION FACTOR, SKN-1, IN CAENORHABDITIS ELEGANS Katie C. McCallum Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Cellular and Molecular Physiology Commons, Medicine and Health Sciences Commons, Molecular Genetics Commons, and the Organismal Biological Physiology Commons Recommended Citation McCallum, Katie C., "THE THIOREDOXIN TRX-1 REGULATES THE MAJOR OXIDATIVE STRESS RESPONSE TRANSCRIPTION FACTOR, SKN-1, IN CAENORHABDITIS ELEGANS" (2016). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 655. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/655 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. THE THIOREDOXIN TRX-1 REGULATES THE MAJOR OXIDATIVE STRESS RESPONSE TRANSCRIPTION FACTOR, SKN-1, IN CAENORHABDITIS ELEGANS A DISSERTATION Presented to the Faculty of The University of Texas Health Science Center at Houston and The University of Texas MD Anderson Cancer Center Graduate School of Biomedical Sciences in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY by Katie Carol McCallum, B.S.
    [Show full text]
  • Retinoblastoma Protein Positively Regulates Terminal Adipocyte Differentiation Through Direct Interaction with C/Ebps
    Downloaded from genesdev.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs Phang-Lang Chen, Daniel J. Riley, Yumay Chen, and Wen-Hwa Lee l Center for Molecular Medicine, Institute of Biotechnology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245 USA To define a mechanism by which retinoblastoma protein (Rb) functions in cellular differentiation, we studied primary fibroblasts from the lung buds of wild-type (RB + / +) and null-mutant (RB-/-) mouse embryos. In culture, the RB +/+ fibroblasts differentiated into fat-storing cells, either spontaneously or in response to hormonal induction; otherwise syngenic RB -/- fibroblasts cultured in identical conditions did not. Ectopic expression of normal Rb, but not Rb with a single point mutation, enabled RB-/- fibroblasts to differentiate into adipocytes. Rb appears in murine fibroblasts to activate CCAAT/enhancer-binding proteins (C/EBPs), a family of transcription factors crucial for adipocyte differentiation. Physical interaction between Rb and C/EBPs was demonstrated by reciprocal coimmunoprecipitation, but occurred only in differentiating cells. Wild-type Rb also enhanced the binding of C/EBP to cognate DNA sequences in vitro and the transact[vat[on of a C/EBPl$-responsive promoter in cells. Taken together, these observations establish a direct and positive role for Rb in terminal differentiation. Such a role contrasts with the function of Rb in arresting cell cycle progression in G1 by negative regulation of other transcription factors like E2F-1. [Key Words: C/EBP; transcription factors; cell cycle; adipocyte differentiation; tumor suppressor protein] Received July 18, 1996; revised version accepted September 5, 1996.
    [Show full text]
  • Locating Mammalian Transcription Factor Binding Sites: a Survey of Computational and Experimental Techniques
    Downloaded from genome.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Review Locating mammalian transcription factor binding sites: A survey of computational and experimental techniques Laura Elnitski,1,4 Victor X. Jin,2 Peggy J. Farnham,2 and Steven J.M. Jones3 1Genomic Functional Analysis Section, National Human Genome Research Institute, National Institutes of Health, Rockville, Maryland 20878, USA; 2Genome and Biomedical Sciences Facility, University of California–Davis, Davis, California 95616-8645, USA; 3Genome Sciences Centre, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada V5Z-4E6 Fields such as genomics and systems biology are built on the synergism between computational and experimental techniques. This type of synergism is especially important in accomplishing goals like identifying all functional transcription factor binding sites in vertebrate genomes. Precise detection of these elements is a prerequisite to deciphering the complex regulatory networks that direct tissue specific and lineage specific patterns of gene expression. This review summarizes approaches for in silico, in vitro, and in vivo identification of transcription factor binding sites. A variety of techniques useful for localized- and high-throughput analyses are discussed here, with emphasis on aspects of data generation and verification. [Supplemental material is available online at www.genome.org.] One documented goal of the National Human Genome Research and other regulatory elements is mediated by DNA/protein in- Institute (NHGRI) is the identification of all functional noncod- teractions. Thus, one major step in the characterization of the ing elements in the human genome (ENCODE Project Consor- functional elements of the human genome is the identification tium 2004).
    [Show full text]
  • Specificity Landscapes Unmask Submaximal Binding Site Preferences of Transcription Factors
    Specificity landscapes unmask submaximal binding site preferences of transcription factors Devesh Bhimsariaa,b,1, José A. Rodríguez-Martíneza,2, Junkun Panc, Daniel Rostonc, Elif Nihal Korkmazc, Qiang Cuic,3, Parameswaran Ramanathanb, and Aseem Z. Ansaria,d,4 aDepartment of Biochemistry, University of Wisconsin–Madison, Madison, WI 53706; bDepartment of Electrical and Computer Engineering, University of Wisconsin–Madison, Madison, WI 53706; cDepartment of Chemistry, University of Wisconsin–Madison, Madison, WI 53706; and dThe Genome Center of Wisconsin, University of Wisconsin–Madison, Madison, WI 53706 Edited by Michael Levine, Princeton University, Princeton, NJ, and approved September 24, 2018 (received for review July 13, 2018) We have developed Differential Specificity and Energy Landscape Here, we report the development of Differential Specificity (DiSEL) analysis to comprehensively compare DNA–protein inter- and Energy Landscapes (DiSEL) to compare experimental actomes (DPIs) obtained by high-throughput experimental plat- platforms, computational methods, and interactomes of TFs, forms and cutting edge computational methods. While high-affinity especially those factors that bind identical consensus motifs. Our DNA binding sites are identified by most methods, DiSEL uncovered results reveal that (i) most high-throughput experimental plat- nuanced sequence preferences displayed by homologous transcription forms reliably identify high-affinity motifs but yield less reliable factors. Pairwise analysis of 726 DPIs uncovered homolog-specific dif- information on submaximal sites; (ii) with few exceptions, com- ferences at moderate- to low-affinity binding sites (submaximal sites). putational methods model DPIs with a focus on high-affinity DiSEL analysis of variants of 41 transcription factors revealed that sites; (iii) submaximal sites improve the annotation of biologi- many disease-causing mutations result in allele-specific changes in cally relevant binding sites across genomes; (iv) among members binding site preferences.
    [Show full text]
  • Dimerization Specificity of Myogenic Helix-Loop-Helix DNA-Binding Factors Directed by Nonconserved Hydrophilic Residues
    Downloaded from genesdev.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press Dimerization specificity of myogenic helix-loop-helix DNA-binding factors directed by nonconserved hydrophilic residues Masaki Shirakata, Fred K. Friedman, 1 Qin Wei, and Bruce M. Paterson Laboratory of Biochemistry, ~Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 USA The myogenic regulatory factor MyoD dimerizes with other positive and negative regulatory factors through a conserved region called the helix-loop-helix (HLH) domain. Using a non-DNA-binding MyoD mutant with a normal HLH domain as a dimerization competitor in gel mobility shift assays in conjunction with various MyoD HLH mutants, nonhydrophobic amino acids were identified in the HLH domain that contribute to dimerization specificity with El2. The assay detected subtle differences in dimerization activity among the mutant MyoD proteins that correlated with their ability to activate transcription in vivo, but this correlation was not apparent in the absence of competitor. The identification of such nonhydrophobic residues enabled us to predict the differences in dimerization affinity among the four vertebrate myogenic factors with El2. The experiments confirmed the prediction. Furthermore, a high-affinity homodimerizing analog of MyoD was designed by a single substitution at one of these residue positions. These experimental results were strengthened when they were analyzed in terms of the crystal structure for the Max bHLHZip domain homodimer. This analysis has allowed us to identify those residues that form charged residue pairs between the two HLH domains of MyoD and El2 and determine the dimerization specificity of the bHLH proteins.
    [Show full text]
  • Domain Structure of the Glucocorticoid Receptor Protein
    Proc. Nati. Acad. Sci. USA Vol. 84, pp. 4437-4440, July 1987 Biochemistry Domain structure of the glucocorticoid receptor protein (proteolysis/steroid binding/DNA binding/protein sequence) JAN CARLSTEDT-DUKE*, PER-ERIK STROMSTEDT*, ORJAN WRANGEt, TOMAS BERGMANt, JAN-AKE GuSTAFSSON*, AND HANS JORNVALLf *Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital, F69, S-141 86 Huddinge, Sweden; and Departments of tMedical Cell Genetics and tChemistry, Karolinska Institute, Box 60400, S-104 01 Stockholm, Sweden Communicated by Viktor Mutt, March 26, 1987 (receivedfor review December 1, 1986) ABSTRACT The purified rat liver glucocorticoid receptor GR was eluted with 27.5 mM MgCl2 and further purified by protein was analyzed by limited proteolysis and amino acid chromatography on DEAE-Sepharose, eluted with a linear sequence determination. The NH2 terminus appears to be NaCl gradient. The receptor was detected by analysis for 3H blocked. The steroid-binding domain, defined by a unique radioactivity. Each purification resulted in a yield of '50 ,g tryptic cleavage site, corresponds to the COOH-terminal part of GR, starting from eight rat livers. The purified prepara- of the protein with the domain border in the region of residue tions of GR contained the 94-kDa GR, the 72-kDa GR- 518. The DNA-binding domain, defined by a region with associated protein that is unrelated to GR (12, 13), as well as chymotryptic cleavage sites, is immediately adjacent to the very small amounts of proteolytic GR fragments (usually steroid-binding domain and reflects another domain border in <5% of total protein according to densitometric analysis of the region of residues 410-414.
    [Show full text]
  • Leucine Zippers
    Leucine Zippers Leucine Zippers Advanced article Toshio Hakoshima, Nara Institute of Science and Technology, Nara, Japan Article contents Introduction The leucine zipper (ZIP) motif consists of a periodic repetition of a leucine residue at every Structural Basis of ZIP seventh position and forms an a-helical conformation, which facilitates dimerization and in Occurrence of ZIP and Coiled-coil Motifs some cases higher oligomerization of proteins. In many eukaryotic gene regulatory proteins, Dimerization Specificity of ZIP the ZIP motif is flanked at its N-terminus by a basic region containing characteristic residues DNA-binding Specificity of bZIP that facilitate DNA binding. doi: 10.1038/npg.els.0005049 Introduction protein modules for protein–protein interactions. Knowing the structure and function of these motifs A structure referred to as the leucine zipper or enables us to understand the molecular recognition simply as ZIP has been proposed to explain how a system in several biological processes. class of eukaryotic gene regulatory proteins works (Landschulz et al., 1988). A segment of the mammalian CCAAT/enhancer binding protein (C/EBP) of 30 Structural Basis of ZIP amino acids shares notable sequence similarity with a segment of the cellular Myc transforming protein. The The a helix is a secondary structure element that segments have been found to contain a periodic occurs frequently in proteins. Alpha helices are repetition of a leucine residue at every seventh stabilized in proteins by being packed into the position. A periodic array of at least four leucines hydrophobic core of a protein through hydrophobic has also been noted in the sequences of the Fos and side chains.
    [Show full text]
  • Nuclear Localization of DP and E2F Transcription Factors by Heterodimeric Partners and Retinoblastoma Protein Family Members
    Journal of Cell Science 109, 1717-1726 (1996) 1717 Printed in Great Britain © The Company of Biologists Limited 1996 JCS7086 Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members Junji Magae1, Chin-Lee Wu2, Sharon Illenye1, Ed Harlow2 and Nicholas H. Heintz1,* 1Department of Pathology, University of Vermont, Burlington VT 05405, USA 2Massachusetts General Hospital Cancer Center, Charlestown MA 02129, USA *Author for correspondence SUMMARY E2F is a family of transcription factors implicated in the showed that regions of E2F-1 and DP-1 that are required regulation of genes required for progression through G1 for stable association of the two proteins were also required and entry into the S phase. The transcriptionally active for nuclear localization of DP-1. Unlike E2F-1, -2, and -3, forms of E2F are heterodimers composed of one polypep- E2F-4 did not accumulate in the nucleus unless it was coex- tide encoded by the E2F gene family and one polypeptide pressed with DP-2. p107 and p130, but not pRb, stimulated encoded by the DP gene family. The transcriptional activity nuclear localization of E2F-4, either alone or in combina- of E2F/DP heterodimers is influenced by association with tion with DP-2. These results indicate that DP proteins the members of the retinoblastoma tumor suppressor preferentially associate with specific E2F partners, and protein family (pRb, p107, and p130). Here the intracellu- suggest that the ability of specific E2F/DP heterodimers to lar distribution of E2F and DP proteins was investigated in localize in the nucleus contributes to the regulation of E2F transiently transfected Chinese hamster and human cells.
    [Show full text]
  • Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook
    International Journal of Molecular Sciences Review Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook Naila Qayyum 1,†, Muhammad Haseeb 1,† , Moon Suk Kim 1 and Sangdun Choi 1,2,* 1 Department of Molecular Science and Technology, Ajou University, Suwon 16499, Korea; [email protected] (N.Q.); [email protected] (M.H.); [email protected] (M.S.K.) 2 S&K Therapeutics, Woncheon Hall 135, Ajou University, Suwon 16499, Korea * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Thioredoxin-interacting protein (TXNIP), widely known as thioredoxin-binding protein 2 (TBP2), is a major binding mediator in the thioredoxin (TXN) antioxidant system, which involves a reduction-oxidation (redox) signaling complex and is pivotal for the pathophysiology of some diseases. TXNIP increases reactive oxygen species production and oxidative stress and thereby contributes to apoptosis. Recent studies indicate an evolving role of TXNIP in the pathogenesis of complex diseases such as metabolic disorders, neurological disorders, and inflammatory illnesses. In addition, TXNIP has gained significant attention due to its wide range of functions in energy metabolism, insulin sensitivity, improved insulin secretion, and also in the regulation of glucose and tumor suppressor activities in various cancers. This review aims to highlight the roles of TXNIP in the field of diabetology, neurodegenerative diseases, and inflammation. TXNIP is found to be a promising novel therapeutic target in the current review, not only in the aforementioned diseases but also in prolonged microvascular and macrovascular diseases. Therefore, TXNIP inhibitors hold promise for preventing the growing incidence of complications in relevant diseases.
    [Show full text]
  • RB1 and P53 at the Crossroad of EMT and Triple Negative Breast Cancer
    PERSPECTIVE PERSPECTIVE Cell Cycle 10:10, 1-8; May 15, 2011; © 2011 Landes Bioscience RB1 and p53 at the crossroad of EMT and triple negative breast cancer Zhe Jiang,1 Robert Jones,1 Jeff C. Liu,1 Tao Deng,1 Tyler Robinson,1 Philip E.D. Chung,1 Sharon Wang,1 Jason I. Herschkowitz,2 Sean E. Egan,3 Charles M. Perou4 and Eldad Zacksenhaus1,* 1Division of Cell and Molecular Biology; Toronto General Research Institute; University Health Network; Toronto, Ontario, Canada; 2Department of Molecular and Cellular Biology; Baylor College of Medicine; Houston, TX USA; 3Program in Developmental and Stem Cell Biology; The Hospital for Sick Children; Department of Molecular Genetics; University of Toronto; Toronto, Ontario, Canada; 4Lineberger Comprehensive Cancer Center; Department of Genetics and Pathology; University of North Carolina at Chapel Hill; Chapel Hill, NC USA riple negative breast cancer (TNBC) NEU-positive and Triple Negative (TN) Tis a heterogeneous disease that tumors, the latter of which do not express includes Basal-like and Claudin-low hormone receptors or HER2.1-7 TNBC tumors. The Claudin-low tumors are affects 15–30% of patients. By IHC it can enriched for features associated with be further divided into Basal-like breast epithelial-to-mesenchymal transition cancer and non-basal tumors, some of (EMT) and possibly for tumor initiating which exhibit features of EMT.8 Basal-like cells. Primary TNBCs respond relatively BCs express the basal cytokeratins (CK) well to conventional chemotherapy; CK5/6, CK14, CK17, and/or epidermal © 2011 Landes Bioscience. Landes ©2011 however, metastatic disease is virtually growth factor receptor (EGFR), whereas incurable.
    [Show full text]
  • Is Glyceraldehyde-3-Phosphate Dehydrogenase a Central Redox Mediator?
    1 Is glyceraldehyde-3-phosphate dehydrogenase a central redox mediator? 2 Grace Russell, David Veal, John T. Hancock* 3 Department of Applied Sciences, University of the West of England, Bristol, 4 UK. 5 *Correspondence: 6 Prof. John T. Hancock 7 Faculty of Health and Applied Sciences, 8 University of the West of England, Bristol, BS16 1QY, UK. 9 [email protected] 10 11 SHORT TITLE | Redox and GAPDH 12 13 ABSTRACT 14 D-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an immensely important 15 enzyme carrying out a vital step in glycolysis and is found in all living organisms. 16 Although there are several isoforms identified in many species, it is now recognized 17 that cytosolic GAPDH has numerous moonlighting roles and is found in a variety of 18 intracellular locations, but also is associated with external membranes and the 19 extracellular environment. The switch of GAPDH function, from what would be 20 considered as its main metabolic role, to its alternate activities, is often under the 21 influence of redox active compounds. Reactive oxygen species (ROS), such as 22 hydrogen peroxide, along with reactive nitrogen species (RNS), such as nitric oxide, 23 are produced by a variety of mechanisms in cells, including from metabolic 24 processes, with their accumulation in cells being dramatically increased under stress 25 conditions. Overall, such reactive compounds contribute to the redox signaling of the 26 cell. Commonly redox signaling leads to post-translational modification of proteins, 27 often on the thiol groups of cysteine residues. In GAPDH the active site cysteine can 28 be modified in a variety of ways, but of pertinence, can be altered by both ROS and 29 RNS, as well as hydrogen sulfide and glutathione.
    [Show full text]
  • The Function and Evolution of C2H2 Zinc Finger Proteins and Transposons
    The function and evolution of C2H2 zinc finger proteins and transposons by Laura Francesca Campitelli A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Molecular Genetics University of Toronto © Copyright by Laura Francesca Campitelli 2020 The function and evolution of C2H2 zinc finger proteins and transposons Laura Francesca Campitelli Doctor of Philosophy Department of Molecular Genetics University of Toronto 2020 Abstract Transcription factors (TFs) confer specificity to transcriptional regulation by binding specific DNA sequences and ultimately affecting the ability of RNA polymerase to transcribe a locus. The C2H2 zinc finger proteins (C2H2 ZFPs) are a TF class with the unique ability to diversify their DNA-binding specificities in a short evolutionary time. C2H2 ZFPs comprise the largest class of TFs in Mammalian genomes, including nearly half of all Human TFs (747/1,639). Positive selection on the DNA-binding specificities of C2H2 ZFPs is explained by an evolutionary arms race with endogenous retroelements (EREs; copy-and-paste transposable elements), where the C2H2 ZFPs containing a KRAB repressor domain (KZFPs; 344/747 Human C2H2 ZFPs) are thought to diversify to bind new EREs and repress deleterious transposition events. However, evidence of the gain and loss of KZFP binding sites on the ERE sequence is sparse due to poor resolution of ERE sequence evolution, despite the recent publication of binding preferences for 242/344 Human KZFPs. The goal of my doctoral work has been to characterize the Human C2H2 ZFPs, with specific interest in their evolutionary history, functional diversity, and coevolution with LINE EREs.
    [Show full text]